Accession Number: | 0001104659-22-129514 |
Date: | 2022-12-22 |
Issuer: | ALTIMMUNE, INC. (ALT) |
Original Submission Date: |
PISANO WAYNE
C/O ALTIMMUNE, INC., 910 CLOPPER ROAD
SUITE 201S
GAITHERSBURG, MD 20878
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, PAR VALUE $0.0001 | 2022-12-22 | M | 20,000 | a | $2.60 | 28,498 | direct | ||
COMMON STOCK, PAR VALUE $0.0001 | 2022-12-22 | S | 20,000 | d | $15.01 | 8,498 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS (OPTION TO BUY) | 2.6 | 2022-12-22 | deemed execution date | M | 20,000 (d) | 2029-01-02 | common stock, par value $0.0001 20,000 | $2.60 | 0 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $15.0000 to $15.0900, inclusive. the reporting person undertakes to provide to altimmune, inc., any security holder of altimmune, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
f3 | the option became vested and exercisable in two equal installments on february 28, 2019 and august 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date. |